Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for prolonged bone marrow toxicity after CAR-T therapy
MOH_2022-01-09_010531Phase 2Not yet recruiting
- Sponsor
- ד"ר עפרת ביאר-כץ
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of eltrombopag in bone marrow failure and cytopenia (2 arms), sponsored by ד"ר עפרת ביאר-כץ. Planned start May 2021; status: not yet recruiting.
02
Drugs
eltrombopag
03
Conditions
bone marrow failurecytopenia
Beyond the preview
Go deeper on MOH_2022-01-09_010531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2022-01-09_010531.